{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:09:17Z","timestamp":1791950957550,"version":"4.3.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81804022"],"award-info":[{"award-number":["No. 81804022"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Aims<\/jats:title>\n            <jats:p>Emerging research highlights the considerable therapeutic promise of glycyrrhizic acid (GA) and stem cells used separately for Parkinson\u2019s disease (PD). Nevertheless, the combined effects of GA and adipose-derived mesenchymal stem cells (ADSCs) in PD models have not been thoroughly investigated. This research is designed to evaluate the therapeutic potential of GA combined with ADSCs in vitro and in vivo, and to analyze the underlying molecular mechanisms.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Main methods<\/jats:title>\n            <jats:p>In vitro experiments were performed in SH-SY5Y cell. In vivo experiments were performed in C57BL\/6 mice.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Key findings<\/jats:title>\n            <jats:p>In comparison to other treatment groups, the combination of GA and ADSCs exhibited improved therapeutic effects in vitro. RNA sequencing analysis revealed involvement of autophagy and the PI3K\/AKT\/HIF-1\u03b1 signaling pathway in the treatment. In follow-up research, the combination of GA and ADSCs markedly increased the expression ratios of p-PI3K\/PI3K, p-AKT\/AKT, and p-mTOR\/mTOR proteins in vitro following 1-methyl-4-phenylpyridinium (MPP+) exposure. Besides, the combined treatment downregulated the LC3II\/LC3I expression ratio and Beclin-1 expression levels while upregulating p62, HIF-1\u03b1, and VEGFA expression levels. Similar to 3-MA, results from western blot, transmission electron microscopy (TEM) and immunofluorescence staining (IF) indicated that the combined treatment significantly reduced autophagy. However, treatment with the PI3K inhibitor (LY294002) reversed these increases in the expression ratios of p-PI3K\/PI3K, p-AKT\/AKT, and p-mTOR\/mTOR, as well as the levels of p62, HIF-1\u03b1, and VEGFA. Moreover, LY294002 significantly impaired the autophagy-suppressing effects of the combination treatment. Finally, the combination of GA and ADSCs ameliorated behavioral deficits and pathological damage to dopaminergic neurons in PD mice induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Significance<\/jats:title>\n            <jats:p>The combination of GA and ADSCs displayed remarkable neuroprotective effects in vitro and in vivo. The underlying mechanism involves the regulation of autophagy via the PI3K\/AKT\/HIF-1\u03b1 signaling pathway.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13287-025-04626-6","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:05:20Z","timestamp":1758805520000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Glycyrrhizic acid combined with human adipose-derived MSCs synergistically alleviates the MPP+\/MPTP-induced parkinson\u2019s disease by inducing autophagy through PI3K\/AKT\/HIF-1\u03b1 pathway"],"prefix":"10.1186","volume":"16","author":[{"given":"Xinlang","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiakang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qizhi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4622-9703","authenticated-orcid":false,"given":"Bin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"issue":"10423","key":"4626_CR1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","volume":"403","author":"Y Ben-Shlomo","year":"2024","unstructured":"Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C, San Luciano M, Tanner C. The epidemiology of Parkinson\u2019s disease. Lancet. 2024;403(10423):283\u201392.","journal-title":"Lancet"},{"key":"4626_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1386608","volume":"15","author":"R Bhidayasiri","year":"2024","unstructured":"Bhidayasiri R, Sringean J, Phumphid S, Anan C, Thanawattano C, Deoisres S, et al. The rise of parkinson\u2019s disease is a global challenge, but efforts to tackle this must begin at a National level: a protocol for National digital screening and eat, move, sleep lifestyle interventions to prevent or slow the rise of non-communicable diseases in Thailand. Front Neurol. 2024;15:1386608.","journal-title":"Front Neurol"},{"issue":"5","key":"4626_CR3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s13205-023-03553-8","volume":"13","author":"H Adam","year":"2023","unstructured":"Adam H, Gopinath SCB, Md Arshad MK, Adam T, Parmin NA, Husein I, et al. An update on pathogenesis and clinical scenario for Parkinson\u2019s disease: diagnosis and treatment. 3 Biotech. 2023;13(5):142.","journal-title":"3 Biotech"},{"issue":"10423","key":"4626_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","volume":"403","author":"HR Morris","year":"2024","unstructured":"Morris HR, Spillantini MG, Sue CM, Williams-Gray CH. The pathogenesis of parkinson\u2019s disease. Lancet. 2024;403(10423):293\u2013304.","journal-title":"Lancet"},{"issue":"10291","key":"4626_CR5","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s disease. Lancet. 2021;397(10291):2284\u2013303.","journal-title":"Lancet"},{"key":"4626_CR6","doi-asserted-by":"publisher","first-page":"109571","DOI":"10.1016\/j.intimp.2022.109571","volume":"114","author":"YT Mohamed","year":"2023","unstructured":"Mohamed YT, Salama A, Rabie MA, Abd El Fattah MA. Neuroprotective effect of Secukinumab against rotenone induced parkinson\u2019s disease in rat model: involvement of IL-17, HMGB-1\/TLR4 axis and bdnf\/trkb cascade. Int Immunopharmacol. 2023;114:109571.","journal-title":"Int Immunopharmacol"},{"key":"4626_CR7","doi-asserted-by":"publisher","first-page":"155952","DOI":"10.1016\/j.phymed.2024.155952","volume":"134","author":"LF Qi","year":"2024","unstructured":"Qi LF, Liu Y, Liu S, Xiang L, Liu Z, Liu Q, et al. Phillyrin promotes autophagosome formation in A53T-alphaSyn-induced parkinson\u2019s disease model via modulation of REEP1. Phytomedicine. 2024;134:155952.","journal-title":"Phytomedicine"},{"issue":"6","key":"4626_CR8","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/ana.25364","volume":"84","author":"AJ Espay","year":"2018","unstructured":"Espay AJ, Morgante F, Merola A, Fasano A, Marsili L, Fox SH, Bezard E, Picconi B, Calabresi P, Lang AE. Levodopa-induced dyskinesia in Parkinson disease: current and evolving concepts. Ann Neurol. 2018;84(6):797\u2013811.","journal-title":"Ann Neurol"},{"key":"4626_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231910988","author":"D Tan","year":"2022","unstructured":"Tan D, Tseng HHL, Zhong Z, Wang S, Vong CT, Wang Y. Glycyrrhizic acid and its derivatives: promising candidates for the management of type 2 diabetes mellitus and its complications. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms231910988.","journal-title":"Int J Mol Sci"},{"key":"4626_CR10","doi-asserted-by":"publisher","first-page":"1148258","DOI":"10.3389\/fnins.2023.1148258","volume":"17","author":"P Zulfugarova","year":"2023","unstructured":"Zulfugarova P, Zivari-Ghader T, Maharramova S, Ahmadian E, Eftekhari A, Khalilov R, et al. A mechanistic review of pharmacological activities of homeopathic medicine licorice against neural diseases. Front Neurosci. 2023;17:1148258.","journal-title":"Front Neurosci"},{"issue":"2","key":"4626_CR11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s12640-015-9579-z","volume":"29","author":"S Ojha","year":"2016","unstructured":"Ojha S, Javed H, Azimullah S, Abul Khair SB, Haque ME. Glycyrrhizic acid attenuates neuroinflammation and oxidative stress in rotenone model of Parkinson\u2019s disease. Neurotox Res. 2016;29(2):275\u201387.","journal-title":"Neurotox Res"},{"issue":"5","key":"4626_CR12","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1517\/14728222.2015.1012156","volume":"19","author":"XF Wang","year":"2015","unstructured":"Wang XF, Zhou QM, Lu YY, Zhang H, Huang S, Su SB. Glycyrrhetinic acid potently suppresses breast cancer invasion and metastasis by impairing the p38 MAPK-AP1 signaling axis. Expert Opin Ther Targets. 2015;19(5):577\u201387.","journal-title":"Expert Opin Ther Targets"},{"key":"4626_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/cells10123433","author":"BA Bunnell","year":"2021","unstructured":"Bunnell BA. Adipose tissue-derived mesenchymal stem cells. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10123433.","journal-title":"Cells"},{"key":"4626_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15112637","author":"H Wu","year":"2023","unstructured":"Wu H, Fan Y, Zhang M. Advanced progress in the role of adipose-derived mesenchymal stromal\/stem cells in the application of central nervous system disorders. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15112637.","journal-title":"Pharmaceutics"},{"issue":"1","key":"4626_CR15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s13287-024-03870-6","volume":"15","author":"J Wu","year":"2024","unstructured":"Wu J, Huang S, Yu Y, Lian Q, Liu Y, Dai W, Liu Q, Pan Y, Liu GA, Li K, et al. Human adipose and synovial-derived MSCs synergistically attenuate osteoarthritis by promoting chondrocyte autophagy through FoxO1 signaling. Stem Cell Res Ther. 2024;15(1):261.","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"4626_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/gpsych-2023-101143","volume":"36","author":"X Xie","year":"2023","unstructured":"Xie X, Song Q, Dai C, Cui S, Tang R, Li S, et al. Clinical safety and efficacy of allogenic human adipose mesenchymal stromal cells-derived exosomes in patients with mild to moderate Alzheimer\u2019s disease: a phase I\/II clinical trial. Gen Psychiatr. 2023;36(5):e101143.","journal-title":"Gen Psychiatr"},{"key":"4626_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218129","author":"H Park","year":"2020","unstructured":"Park H, Chang KA. Therapeutic potential of repeated intravenous transplantation of human adipose-derived stem cells in subchronic MPTP-induced Parkinson\u2019s disease mouse model. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21218129.","journal-title":"Int J Mol Sci"},{"key":"4626_CR18","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3389\/fphys.2018.00991","volume":"9","author":"J Chen","year":"2018","unstructured":"Chen J, Wei J, Huang Y, Ma Y, Ni J, Li M, Zhu Y, Gao X, Fan G. Danhong injection enhances the therapeutic efficacy of mesenchymal stem cells in myocardial infarction by promoting angiogenesis. Front Physiol. 2018;9:991.","journal-title":"Front Physiol"},{"key":"4626_CR19","unstructured":"Shenzhong J, Han W, Chengxian Y, Feng F, Dan X, Mengyu Z, Manqing X, Ruixue C, Zhaohui Z, Chenhao J et al. Phase 1 study of safety and preliminary efficacy of intranasal transplantation of human neural stem cells (ANGE-S003) in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 2024(0)."},{"issue":"12","key":"4626_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2023.168144","volume":"435","author":"C Themistokleous","year":"2023","unstructured":"Themistokleous C, Bagnoli E, Parulekar R, Muqit MMK. Role of autophagy pathway in Parkinson\u2019s disease and related genetic neurological disorders. J Mol Biol. 2023;435(12):168144.","journal-title":"J Mol Biol"},{"key":"4626_CR21","doi-asserted-by":"publisher","first-page":"1518991","DOI":"10.3389\/fcell.2025.1518991","volume":"13","author":"M Sakurai","year":"2025","unstructured":"Sakurai M, Kuwahara T. Canonical and noncanonical autophagy: involvement in parkinson\u2019s disease. Front Cell Dev Biol. 2025;13:1518991.","journal-title":"Front Cell Dev Biol"},{"key":"4626_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/biom13101435","author":"L Nechushtai","year":"2023","unstructured":"Nechushtai L, Frenkel D, Pinkas-Kramarski R. Autophagy in Parkinson\u2019s disease. Biomolecules. 2023. https:\/\/doi.org\/10.3390\/biom13101435.","journal-title":"Biomolecules"},{"key":"4626_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cells9112399","author":"A Navarro-Romero","year":"2020","unstructured":"Navarro-Romero A, Montpeyo M, Martinez-Vicente M. The emerging role of the lysosome in Parkinson\u2019s disease. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9112399.","journal-title":"Cells"},{"key":"4626_CR24","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.3389\/fonc.2019.01431","volume":"9","author":"S Cai","year":"2019","unstructured":"Cai S, Bi Z, Bai Y, Zhang H, Zhai D, Xiao C, Tang Y, Yang L, Zhang X, Li K, et al. Glycyrrhizic Acid-Induced differentiation repressed stemness in hepatocellular carcinoma by targeting c-Jun N-Terminal kinase 1. Front Oncol. 2019;9:1431.","journal-title":"Front Oncol"},{"issue":"Pt A","key":"4626_CR25","doi-asserted-by":"publisher","first-page":"115875","DOI":"10.1016\/j.jep.2022.115875","volume":"302","author":"P Liu","year":"2023","unstructured":"Liu P, Xu Y, Ye J, Tan J, Hou J, Wang Y, et al. Qingre huazhuo jiangsuan decoction promotes autophagy by inhibiting PI3K\/AKT\/mTOR signaling pathway to relieve acute gouty arthritis. J Ethnopharmacol. 2023;302(Pt A):115875.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"4626_CR26","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s40001-022-00820-x","volume":"27","author":"Y Chen","year":"2022","unstructured":"Chen Y, Pan X, Zhao J, Li C, Lin Y, Wang Y, Liu X, Tian M. Icariin alleviates osteoarthritis through PI3K\/Akt\/mTOR\/ULK1 signaling pathway. Eur J Med Res. 2022;27(1):204.","journal-title":"Eur J Med Res"},{"issue":"12","key":"4626_CR27","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1016\/j.cellsig.2014.08.019","volume":"26","author":"D Heras-Sandoval","year":"2014","unstructured":"Heras-Sandoval D, Perez-Rojas JM, Hernandez-Damian J, Pedraza-Chaverri J. The role of PI3K\/AKT\/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration. Cell Signal. 2014;26(12):2694\u2013701.","journal-title":"Cell Signal"},{"key":"4626_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/biology10080723","author":"L Lest\u00f3n Pinilla","year":"2021","unstructured":"Lest\u00f3n Pinilla L, Ugun-Klusek A, Rutella S, De Girolamo LA. Hypoxia signaling in Parkinson\u2019s disease: there is use in asking what HIF? Biology. 2021. https:\/\/doi.org\/10.3390\/biology10080723.","journal-title":"Biology"},{"key":"4626_CR29","doi-asserted-by":"crossref","unstructured":"Fu G, Kang X, Lin S. Glycyrrhizic acid inhibits hippocampal neuron apoptosis by activating the PI3K\/ AKT signaling pathway. Biochem Genet 2024.","DOI":"10.1007\/s10528-024-10936-w"},{"issue":"5","key":"4626_CR30","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/mc.23515","volume":"62","author":"Z Jin","year":"2023","unstructured":"Jin Z, Xiang R, Dai J, Wang Y, Xu Z. HIF-1\u03b1 mediates CXCR4 transcription to activate the akt\/mtor signaling pathway and augment the viability and migration of activated B cell-like diffuse large B-cell lymphoma cells. Mol Carcinog. 2023;62(5):676\u201384.","journal-title":"Mol Carcinog"},{"key":"4626_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176819","volume":"980","author":"R Lal","year":"2024","unstructured":"Lal R, Singh A, Watts S, Chopra K. Experimental models of Parkinson\u2019s disease: challenges and opportunities. Eur J Pharmacol. 2024;980:176819.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"4626_CR32","first-page":"51","volume":"65","author":"A Gugliandolo","year":"2016","unstructured":"Gugliandolo A, Bramanti P, Mazzon E. Mesenchymal stem cell therapy in parkinson\u2019s disease animal models. Curr Res Transl Med. 2016;65(2):51\u201360.","journal-title":"Curr Res Transl Med"},{"key":"4626_CR33","unstructured":"Division of Nephrology DoIMI, Hospital U, Division for Allergy G-U, Adolescents Medicine P et al. UHF, Goethe University, 60596 Frankfurt am Main, Germany., Experimental Immunology DfC, Adolescents Medicine UHF, Goethe University, 60596 Frankfurt am Main, Germany. Tracking of Infused Mesenchymal Stem Cells in Injured Pulmonary Tissue in Atm-Deficient Mice. Cells : 2020, 9(6)."},{"issue":"10","key":"4626_CR34","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1016\/j.neurobiolaging.2015.06.022","volume":"36","author":"HS Choi","year":"2015","unstructured":"Choi HS, Kim HJ, Oh J-H, Park H-G, Ra JC, Chang K-A, et al. Therapeutic potentials of human adipose-derived stem cells on the mouse model of parkinson\u2019s disease. Neurobiol Aging. 2015;36(10):2885\u201392.","journal-title":"Neurobiol Aging"},{"issue":"11 Pt 1","key":"4626_CR35","first-page":"3751","volume":"38","author":"JL Biedler","year":"1978","unstructured":"Biedler JL, Roffler-Tarlov S, Schachner M, Freedman LS. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res. 1978;38(11 Pt 1):3751\u20137.","journal-title":"Cancer Res"},{"issue":"1","key":"4626_CR36","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13287-020-01636-4","volume":"11","author":"C Zhou","year":"2020","unstructured":"Zhou C, Li M, Zhang Y, Ni M, Wang Y, Xu D, Shi Y, Zhang B, Chen Y, Huang Y, et al. Autologous adipose-derived stem cells for the treatment of crohn\u2019s fistula-in-ano: an open-label, controlled trial. Stem Cell Res Ther. 2020;11(1):124.","journal-title":"Stem Cell Res Ther"},{"key":"4626_CR37","doi-asserted-by":"crossref","unstructured":"Zhu M, Heydarkhan-Hagvall S, Hedrick M, Benhaim P, Zuk P. Manual isolation of adipose-derived stem cells from human lipoaspirates. J Vis Exp 2013;(79):e50585.","DOI":"10.3791\/50585-v"},{"issue":"3","key":"4626_CR38","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s11064-014-1477-x","volume":"40","author":"G Hua","year":"2015","unstructured":"Hua G, Xiaolei L, Weiwei Y, Hao W, Yuangang Z, Dongmei L, Yazhuo Z, Hui Y. Protein phosphatase 2A is involved in the tyrosine hydroxylase phosphorylation regulated by \u03b1-synuclein. Neurochem Res. 2015;40(3):428\u201337.","journal-title":"Neurochem Res"},{"issue":"24","key":"4626_CR39","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.3390\/cells12242860","volume":"12","author":"LF Cardo","year":"2023","unstructured":"Cardo LF, Sandoval JM, Li Z, Webber C, Li M. Single-cell transcriptomics and in vitro lineage tracing reveals differential susceptibility of human iPSC-derived midbrain dopaminergic neurons in a cellular model of parkinson\u2019s disease. Cells. 2023;12(24):2860.","journal-title":"Cells"},{"issue":"6","key":"4626_CR40","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2174\/1574888X09666140923101110","volume":"9","author":"T Tanna","year":"2014","unstructured":"Tanna T, Sachan V. Mesenchymal stem cells: potential in treatment of neurodegenerative diseases. Curr Stem Cell Res Ther. 2014;9(6):513\u201321.","journal-title":"Curr Stem Cell Res Ther"},{"issue":"1","key":"4626_CR41","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1039\/C9FO01459D","volume":"11","author":"J Tian","year":"2020","unstructured":"Tian J, Li X, Zhao L, Shen P, Wang Z, Zhu L, Li C, Su C, Zhang Y. Glycyrrhizic acid promotes neural repair by directly driving functional remyelination. Food Funct. 2020;11(1):992\u20131005.","journal-title":"Food Funct"},{"issue":"1","key":"4626_CR42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13024-017-0149-0","volume":"12","author":"X Helena","year":"2017","unstructured":"Helena X, B\u00e9 W. The SH-SY5Y cell line in parkinson\u2019s disease research: a systematic review. Mol Neurodegener. 2017;12(1):10.","journal-title":"Mol Neurodegener"},{"issue":"6","key":"4626_CR43","doi-asserted-by":"publisher","first-page":"066038","DOI":"10.1088\/1741-2552\/ad17f3","volume":"20","author":"V Eva","year":"2023","unstructured":"Eva V, Nina D, Marloes L, Jeannette H, Monica F. Degree of differentiation impacts neurobiological signature and resistance to hypoxia of SH-SY5Y cells. J Neural Eng. 2023;20(6):066038.","journal-title":"J Neural Eng"},{"key":"4626_CR44","doi-asserted-by":"publisher","first-page":"1139359","DOI":"10.3389\/fbioe.2023.1139359","volume":"11","author":"I Jasmina","year":"2023","unstructured":"Jasmina I, Klara \u0160, Barbara B, Dinko M. Mesenchymal stem cell therapy for neurological disorders: the light or the dark side of the force? Front Bioeng Biotechnol. 2023;11:1139359\u20131139359.","journal-title":"Front Bioeng Biotechnol"},{"issue":"15","key":"4626_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155241","volume":"21","author":"M d\u2019Angelo","year":"2020","unstructured":"d\u2019Angelo M, Cimini A, Castelli V. Insights into the effects of mesenchymal stem cell-derived secretome in parkinson\u2019s disease. Int J Mol Sci. 2020;21(15):5241.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"4626_CR46","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.3390\/biomedicines10102485","volume":"10","author":"ZZE Isabelle","year":"2022","unstructured":"Isabelle ZZE, Xingchi C, Xuegang C. Exosomal microRNAs as novel cell-free therapeutics in tissue engineering and regenerative medicine. Biomedicines. 2022;10(10):2485\u20132485.","journal-title":"Biomedicines"},{"issue":"6","key":"4626_CR47","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.1002\/alz.13847","volume":"20","author":"Y Hou","year":"2024","unstructured":"Hou Y, Chu X, Park JH, Zhu Q, Hussain M, Li Z, et al. Urolithin A improves alzheimer\u2019s disease cognition and restores mitophagy and lysosomal functions. Alzheimers Dement. 2024;20(6):4212\u201333.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"4626_CR48","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41419-020-2473-5","volume":"11","author":"HX Chen","year":"2020","unstructured":"Chen HX, Liang FC, Gu P, Xu BL, Xu HJ, Wang WT, et al. Exosomes derived from mesenchymal stem cells repair a Parkinson\u2019s disease model by inducing autophagy. Cell Death Dis. 2020;11(4):288.","journal-title":"Cell Death Dis"},{"issue":"10","key":"4626_CR49","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1007\/s11064-018-2609-5","volume":"43","author":"G Yang","year":"2018","unstructured":"Yang G, Li J, Cai Y, Yang Z, Li R, Fu W. Glycyrrhizic acid alleviates 6-hydroxydopamine and corticosterone-induced neurotoxicity in SH-SY5Y cells through modulating autophagy. Neurochem Res. 2018;43(10):1914\u201326.","journal-title":"Neurochem Res"},{"key":"4626_CR50","doi-asserted-by":"publisher","first-page":"4636397","DOI":"10.1155\/2020\/4636397","volume":"2020","author":"YL Wang","year":"2020","unstructured":"Wang YL, Liu XS, Wang SS, Xue P, Zeng ZL, Yang XP, Zhang SM, Zheng W, Hua L, Li JF, et al. Curcumin-activated mesenchymal stem cells derived from human umbilical cord and their effects on MPTP-mouse model of Parkinson\u2019s disease: a new biological therapy for Parkinson\u2019s disease. Stem Cells Int. 2020;2020:4636397.","journal-title":"Stem Cells Int"},{"key":"4626_CR51","doi-asserted-by":"publisher","first-page":"15420","DOI":"10.1016\/j.phymed.2022.154250","volume":"104","author":"L-K Wu","year":"2022","unstructured":"Wu L-K, Agarwal S, Kuo C-H, Kung Y-L, Day CH, Lin P-Y, Lin S-Z, Hsieh DJ-Y, Huang C-Y, Chiang C-Y. Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy\/mitophagy clearance in both in vitro and in vivo models of MPP+\/MPTP-induced Parkinson\u2019s disease. Phytomedicine. 2022;104:15420.","journal-title":"Phytomedicine"},{"key":"4626_CR52","doi-asserted-by":"publisher","first-page":"117628","DOI":"10.1016\/j.jep.2023.117628","volume":"322","author":"L Yu","year":"2024","unstructured":"Yu L, Hu X, Xu R, Zhao Y, Xiong L, Ai J, Wang X, Chen X, Ba Y, Xing Z, et al. Piperine promotes PI3K\/AKT\/mTOR-mediated gut-brain autophagy to degrade alpha-Synuclein in parkinson\u2019s disease rats. J Ethnopharmacol. 2024;322:117628.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"4626_CR53","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2353\/ajpath.2007.060524","volume":"170","author":"JH Zhu","year":"2007","unstructured":"Zhu JH, Horbinski C, Guo F, Watkins S, Uchiyama Y, Chu CT. Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death. Am J Pathol. 2007;170(1):75\u201386.","journal-title":"Am J Pathol"},{"issue":"14","key":"4626_CR54","doi-asserted-by":"publisher","first-page":"10850","DOI":"10.1074\/jbc.M109.080796","volume":"285","author":"W You-Tong","year":"2010","unstructured":"You-Tong W, Hui-Ling T, Guanghou S, Chantal B, Qing H, Choon-Nam RWM, Patrice O, Han-Ming C. Dual role of 3-methyladenine in modulation of autophagy via different Temporal patterns of Inhibition on class I and III phosphoinositide 3-kinase. J Biol Chem. 2010;285(14):10850\u201361.","journal-title":"J Biol Chem"},{"issue":"6","key":"4626_CR55","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;168(6):960\u201376.","journal-title":"Cell"},{"key":"4626_CR56","doi-asserted-by":"publisher","first-page":"154644","DOI":"10.1016\/j.phymed.2023.154644","volume":"110","author":"R Li","year":"2023","unstructured":"Li R, Zheng Y, Zhang J, Zhou Y, Fan X. Gomisin N attenuated cerebral ischemia-reperfusion injury through inhibition of autophagy by activating the PI3K\/AKT\/mTOR pathway. Phytomedicine. 2023;110:154644.","journal-title":"Phytomedicine"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04626-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04626-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04626-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T14:03:49Z","timestamp":1758809029000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04626-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4626"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04626-6","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received approval from the Ethics Committee of Nanjing University of Chinese Medicine on December 12, 2024 (Project name: Therapeutic Effects and Mechanisms of Zhigancao Decoction Combined with Adipose-Derived Mesenchymal Stem Cells on Ameliorating MPTP-Induced Parkinson\u2019s Disease in Mice. Ethics Approval Number: A20241201). Our study related to ADSCs was approved by the Ethics Committee of animal experiments at Nanjing Medical University on August 1, 2019 (Project name: Combined treatment with Rg1 and adipose-derived stem cells alleviates DSS-induced colitis in a mouse model. Ethics Approval Number: Ethics No.1181064). The methods were carried out in accordance with the relevant guidelines. Human abdominal or buttock adipose tissues were collected from patients receiving regenerative medicine using ADSCs at Nanjing Hospital of Chinese Medicine. Written informed consent was obtained from all study participants. The SH-SY5Y cell line was obtained from the American Type Culture Collection (CRL-2266, ATCC, ). According to ATCC, the collection of these cells was conducted in compliance with ethical standards, and informed consent was obtained from the donor.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors confirm their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"500"}}